DGAP-News: Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa(TM) in the Middle East and the Gulf
Apricus Biosciences, Inc.
10.01.2012 15:51
—————————————————————————
Apricus Bio to Receive up to $2.1 Million, Plus Royalties
SAN DIEGO and DUBAI, United Arab Emirates, 2012-01-10 15:51 CET (GLOBE
NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio–) (www.apricusbio.com) (Nasdaq:APRI)
and Elis Pharmaceuticals (–Elis–) (www.elispharmaceuticals.com), announced
today that the two companies have entered into a licensing agreement granting
E
